Serotoninergic impairment and aggressive behavior in Alzheimer's disease.

Zarros, A. C. , Kalopita, K. S. and Tsakiris, S. T. (2005) Serotoninergic impairment and aggressive behavior in Alzheimer's disease. Acta Neurobiologiae Experimentalis, 65(3), pp. 277-286. (PMID:16130802)

Full text not currently available from Enlighten.


The overall goal of all therapeutic interventions in Alzheimer's disease (AD) is to: (a) optimize the impaired functions and (b) restore an affordable quality of life for both the patient and his surroundings. AD has been characterized by a significant serotoninergic impairment. It is well known that impaired serotoninergic function is related to aggressive behavior. We, herein, review the past and recent evidence that seems to link the serotoninergic system with aggressive manifestations in AD patients. Managing the aggressive behavior of these patients might be of significant medical, social and economical importance. However, there is still a long way to go until we verify the exact pathophysiological mechanism(s) involved in the induction of aggression in AD patients. The current data underlines a complex relationship between the observed serotoninergic impairment in AD patients and the (a) cholinergic system, (b) the endocrine (hormonal) state, (c) the nutritional habits, (d) the genetic background and (e) the caregiving environment.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Zarros, Dr Apostolos
Authors: Zarros, A. C., Kalopita, K. S., and Tsakiris, S. T.
Subjects:R Medicine > RB Pathology
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Acta Neurobiologiae Experimentalis
Publisher:Polish Academy of Sciences, M. Nencki Institute of Experimental Biology

University Staff: Request a correction | Enlighten Editors: Update this record